Using HIV-1 sequence variability to explore virus biology (Q34284913)

1 August 2017

1 reference

title

Using HIV-1 sequence variability to explore virus biology (English)

1 reference

1 August 2017

McGrath KM

1

1 reference

1 August 2017

Hoffman NG

2

1 reference

1 August 2017

Resch W

3

1 reference

1 August 2017

Nelson JA

4

1 reference

1 August 2017

Swanstrom R

5

1 reference

1 August 2017

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

76

1 reference

1 August 2017

2

1 reference

1 August 2017

137-160

1 reference

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

A new classification for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Forced evolution of a regulatory RNA helix in the HIV-1 genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Isolation of a new human retrovirus from West African patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Identification of a protein encoded by the vpu gene of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Human immunodeficiency virus type 1 populations in blood and semen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

RNA virus mutations and fitness for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Selforganization of matter and the evolution of biological macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Human infection by genetically diverse SIVSM-related HIV-2 in west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Prevalence of HIV-1 and HIV-2 mixed infections in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Chemokines and receptors in HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Genome organization and transactivation of the human immunodeficiency virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Quantitative image analysis of HIV-1 infection in lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

How to resolve the debate on the origin of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

An African primate lentivirus (SIVsm) closely related to HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Investigation of population diversity of human immunodeficiency virus type 1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Diversity of HIV type 1 envelope V3 loop region in saliva.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Search for the origin of HIV and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Timing the ancestor of the HIV-1 pandemic strains

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Limitations of a molecular clock applied to considerations of the origin of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Appearance of autologous neutralizing antibody correlates with reduction in virus load and phenotype switch during primary infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The risk of disease progression is determined during the first year of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

HIV-1: gambling on the evolution of drug resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The molecular clock of HIV-1 unveiled through analysis of a known transmission history

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Turnover of circulating virion RNA and of cell-associated viral DNA reflects active viral replication in human immunodeficiency virus type 1-infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Gender differences in HIV-1 diversity at time of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Co-receptors for HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Rapid generation of sequence variation during primary HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Low level of cell-free virus detected at high frequency in saliva from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Identification of mixed HIV-1/HIV-2 infections in Brazil by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Mechanisms of retroviral mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Recombination in HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Linkage disequilibrium test implies a large effective population number for HIV in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Antibodies Reactive with Human T-Lymphotropic Retroviruses (HTLV-III) in the Serum of Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Cross-species transmission and recombination of ‘AIDS’ viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Distinct Populations of Human Immunodeficiency Virus Type 1 in Blood and Cerebrospinal Fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

The Benign Cystic Lymphoepithelial Lesion of the Parotid Gland Is a Viral Reservoir in HIV Type 1-Infected Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Detection and biologic characterization of infectious HIV-1 in semen of seropositive men

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Sexual transmission of HIV: infectiousness and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Evolutionary dynamics of HIV-induced subversion of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

HIV-1 genomic RNA diversification following sexual and parenteral virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Direct demonstration of retroviral recombination in a rhesus monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Most retroviral recombinations occur during minus-strand DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

An African HIV-1 sequence from 1959 and implications for the origin of the epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2801%2900271-4

7 January 2021

10.1016/S0168-1702(01)00271-4

Identifiers

DOI

1 reference

1 August 2017

1 reference